Bids Are Invited For Acquisition Of Medicines And Supplies To Care For Hras Patients.

Essential Fatty Acids, Composition: Compound Of Caprylic, Capric, Lauric Acids, Components: Linoleic, Soy Lecithin, Presentation: Associated With Vitamins A And E, Type: Oily Lotion, Ampicillin, Composition: Associated With Sulbactam, Concentration: 2 G + 1 G, Pharmaceutical Form: Powder For Injectable Solution, Atenolol, Dosage:50 Mg, Benzylpenicillin, Presentation:Potassic, Dosage:5,000,000Ui, Use:Injectable, Beclomethasone Dipropionate, Composition:Assoc. With Glycopyrronium Bromide And Formoterol, Concentration: 100 + 12.5 + 6 Mcg/Dose, Pharmaceutical Form: Oral Aerosol, Additional Feature: With Inhaler, 04/23/2026 - 15:49:14, 04/23/2026 - 15:49:17, Ceftriaxone Sodium, Concentration:1 G, Ciprofloxacin Hydrochloride, Dosage:2 Mg/Ml, Presentation:Injectable Solution, Radiological Contrast, Type:Non-Ionic, Composition:Iohexol Based, Concentration:300Mg Iodine/Ml, Pharmaceutical Form:Injectable Solution, Chlorhexidine Digluconate, Dosage:2%, Application:Topical Solution, Diethyl Ether, Presentation: Alcoholic Solution, Concentration: 35%, Formaldehyde (Formol), Physical Appearance: Colorless, Clear Liquid, Concentration: 10%, Additional Characteristic: In Buffered Aqueous Solution, Composition: Associated With Formoterol Fumarate, Concentration: 100 Mcg + 6 Mcg /Dose, Aluminum Hydroxide, Composition:Associated With Magnesium Hydroxide, Concentration:60 Mg + 40 Mg/Ml, Pharmaceutical Form:Oral Suspension, Imipenem, Composition:Associated With Cilastatin Sodium, Concentration:500 Mg, Pharmaceutical Form:Lyophilic Powder For Injection, Metoprolol, Active Ingredient:Succinate Salt, Presentation:Controlled Release, Paracetamol, Presentation:Associated With Codeine, Dosage:500Mg + 30Mg, Prednisolone, Composition:Sodium Phosphate, Concentration:3 Mg/Ml, Pharmaceutical Form:Oral Solution